Coeptis Therapeutics Holdings, Inc. (COEP)
Apr 24, 2026 - COEP merged into ZSQR
16.40
+0.19 (1.17%)
Inactive · Last trade price
on Apr 24, 2026
COEP Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Revenue | 1.36 | - | - | - | 0.08 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | 143.81% | Upgrade
|
| Cost of Revenue | 0.18 | - | - | - | - | Upgrade
|
| Gross Profit | 1.18 | - | - | - | 0.08 | Upgrade
|
| Selling, General & Admin | 10.73 | 5.62 | 13.35 | 34.18 | 14.12 | Upgrade
|
| Research & Development | 1.28 | 2.33 | 6.67 | 0.02 | - | Upgrade
|
| Amortization of Goodwill & Intangibles | 1 | 1 | 1 | - | - | Upgrade
|
| Operating Expenses | 14.23 | 10.05 | 21.49 | 34.2 | 14.12 | Upgrade
|
| Operating Income | -13.04 | -10.05 | -21.49 | -34.2 | -14.05 | Upgrade
|
| Interest Expense | -0.64 | -0.46 | -0.11 | -0.22 | -0.19 | Upgrade
|
| Interest & Investment Income | 0.12 | 0.23 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 1.11 | -0.36 | 0.33 | 0.01 | 0.79 | Upgrade
|
| EBT Excluding Unusual Items | -12.46 | -10.64 | -21.27 | -34.41 | -13.45 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.09 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | -0 | Upgrade
|
| Asset Writedown | - | -0.04 | - | - | - | Upgrade
|
| Other Unusual Items | 0.27 | -0.2 | - | -3.17 | - | Upgrade
|
| Pretax Income | -12.28 | -10.88 | -21.27 | -37.57 | -13.45 | Upgrade
|
| Earnings From Continuing Operations | -12.28 | -10.88 | -21.27 | -37.57 | -13.45 | Upgrade
|
| Minority Interest in Earnings | 0.36 | 0.2 | - | - | - | Upgrade
|
| Net Income | -11.92 | -10.68 | -21.27 | -37.57 | -13.45 | Upgrade
|
| Net Income to Common | -11.92 | -10.68 | -21.27 | -37.57 | -13.45 | Upgrade
|
| Shares Outstanding (Basic) | 4 | 2 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 4 | 2 | 1 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | 120.03% | 49.84% | 79.70% | 30.98% | 79.11% | Upgrade
|
| EPS (Basic) | -2.81 | -5.55 | -16.56 | -52.57 | -24.64 | Upgrade
|
| EPS (Diluted) | -2.81 | -5.55 | -16.56 | -52.57 | -24.64 | Upgrade
|
| Free Cash Flow | -8.6 | -6.65 | -7.24 | -3.88 | -4.49 | Upgrade
|
| Free Cash Flow Per Share | -2.03 | -3.46 | -5.64 | -5.42 | -8.23 | Upgrade
|
| Gross Margin | 86.75% | - | - | - | 100.00% | Upgrade
|
| Operating Margin | -956.94% | - | - | - | -18727.91% | Upgrade
|
| Profit Margin | -874.29% | - | - | - | -17932.37% | Upgrade
|
| Free Cash Flow Margin | -631.16% | - | - | - | -5985.92% | Upgrade
|
| EBITDA | -11.86 | -9.05 | -20.49 | -33.19 | -13.6 | Upgrade
|
| D&A For EBITDA | 1.18 | 1 | 1 | 1 | 0.45 | Upgrade
|
| EBIT | -13.04 | -10.05 | -21.49 | -34.2 | -14.05 | Upgrade
|
| Revenue as Reported | 1.36 | - | - | - | 0.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.